Chiesi takes on Seretide and other lung drugs with Trimbow.
Italian pharma gets EU rights to Seloken.
Prototype tested by Tim Cook requires no skin penetration.
Kite, Juno, and BlueBird will give updates on T-cell therapies.
Lanadelumab could revolutionise treatment of swelling disease.
MindMotion Pro helps with upper-limb rehabilitation following a stroke.
Almost a year after launch, ABPI is confident more doctors will disclose payments